nodes	percent_of_prediction	percent_of_DWPC	metapath
Iloperidone—Prostatitis—Octreotide—thymus cancer	0.0801	0.119	CcSEcCtD
Iloperidone—HTR2A—phrenic nerve—thymus cancer	0.0596	0.183	CbGeAlD
Iloperidone—HTR7—pulmonary artery—thymus cancer	0.0347	0.107	CbGeAlD
Iloperidone—HTR7—vein—thymus cancer	0.0316	0.0971	CbGeAlD
Iloperidone—Cholelithiasis—Octreotide—thymus cancer	0.0281	0.0417	CcSEcCtD
Iloperidone—Hypothyroidism—Octreotide—thymus cancer	0.0272	0.0404	CcSEcCtD
Iloperidone—Paranoia—Octreotide—thymus cancer	0.0257	0.038	CcSEcCtD
Iloperidone—Metrorrhagia—Octreotide—thymus cancer	0.0245	0.0363	CcSEcCtD
Iloperidone—Nephrolithiasis—Octreotide—thymus cancer	0.0218	0.0322	CcSEcCtD
Iloperidone—HTR2A—pulmonary artery—thymus cancer	0.0216	0.0665	CbGeAlD
Iloperidone—Endocrine disorder—Octreotide—thymus cancer	0.0211	0.0313	CcSEcCtD
Iloperidone—Breast pain—Octreotide—thymus cancer	0.02	0.0297	CcSEcCtD
Iloperidone—Amenorrhoea—Octreotide—thymus cancer	0.0199	0.0295	CcSEcCtD
Iloperidone—HTR2A—vein—thymus cancer	0.0197	0.0606	CbGeAlD
Iloperidone—Mouth ulceration—Octreotide—thymus cancer	0.0158	0.0234	CcSEcCtD
Iloperidone—Gynaecomastia—Octreotide—thymus cancer	0.0156	0.0232	CcSEcCtD
Iloperidone—Nasal congestion—Octreotide—thymus cancer	0.0139	0.0207	CcSEcCtD
Iloperidone—Amnesia—Octreotide—thymus cancer	0.0135	0.02	CcSEcCtD
Iloperidone—Psychotic disorder—Octreotide—thymus cancer	0.0124	0.0184	CcSEcCtD
Iloperidone—Dehydration—Octreotide—thymus cancer	0.0118	0.0175	CcSEcCtD
Iloperidone—Nasopharyngitis—Octreotide—thymus cancer	0.0114	0.0168	CcSEcCtD
Iloperidone—Gastritis—Octreotide—thymus cancer	0.0112	0.0167	CcSEcCtD
Iloperidone—Asthma—Octreotide—thymus cancer	0.011	0.0163	CcSEcCtD
Iloperidone—Abdominal discomfort—Octreotide—thymus cancer	0.0105	0.0156	CcSEcCtD
Iloperidone—Dysuria—Octreotide—thymus cancer	0.0103	0.0152	CcSEcCtD
Iloperidone—Upper respiratory tract infection—Octreotide—thymus cancer	0.0102	0.0151	CcSEcCtD
Iloperidone—Pollakiuria—Octreotide—thymus cancer	0.0101	0.015	CcSEcCtD
Iloperidone—Weight increased—Octreotide—thymus cancer	0.00999	0.0148	CcSEcCtD
Iloperidone—Weight decreased—Octreotide—thymus cancer	0.00993	0.0147	CcSEcCtD
Iloperidone—Conjunctivitis—Octreotide—thymus cancer	0.00951	0.0141	CcSEcCtD
Iloperidone—Hepatobiliary disease—Octreotide—thymus cancer	0.00925	0.0137	CcSEcCtD
Iloperidone—Epistaxis—Octreotide—thymus cancer	0.00923	0.0137	CcSEcCtD
Iloperidone—Tinnitus—Octreotide—thymus cancer	0.00819	0.0121	CcSEcCtD
Iloperidone—Cardiac disorder—Octreotide—thymus cancer	0.00815	0.0121	CcSEcCtD
Iloperidone—Arrhythmia—Octreotide—thymus cancer	0.00785	0.0116	CcSEcCtD
Iloperidone—Mental disorder—Octreotide—thymus cancer	0.00769	0.0114	CcSEcCtD
Iloperidone—Malnutrition—Octreotide—thymus cancer	0.00764	0.0113	CcSEcCtD
Iloperidone—Muscle spasms—Octreotide—thymus cancer	0.00735	0.0109	CcSEcCtD
Iloperidone—Vision blurred—Octreotide—thymus cancer	0.0072	0.0107	CcSEcCtD
Iloperidone—HTR7—neck—thymus cancer	0.00717	0.022	CbGeAlD
Iloperidone—Tremor—Octreotide—thymus cancer	0.00716	0.0106	CcSEcCtD
Iloperidone—Anaemia—Octreotide—thymus cancer	0.00707	0.0105	CcSEcCtD
Iloperidone—Agitation—Octreotide—thymus cancer	0.00703	0.0104	CcSEcCtD
Iloperidone—Vertigo—Octreotide—thymus cancer	0.00687	0.0102	CcSEcCtD
Iloperidone—Palpitations—Octreotide—thymus cancer	0.00676	0.01	CcSEcCtD
Iloperidone—Arthralgia—Octreotide—thymus cancer	0.00651	0.00965	CcSEcCtD
Iloperidone—Myalgia—Octreotide—thymus cancer	0.00651	0.00965	CcSEcCtD
Iloperidone—Dry mouth—Octreotide—thymus cancer	0.00637	0.00944	CcSEcCtD
Iloperidone—Oedema—Octreotide—thymus cancer	0.00624	0.00925	CcSEcCtD
Iloperidone—Infection—Octreotide—thymus cancer	0.0062	0.00919	CcSEcCtD
Iloperidone—Nervous system disorder—Octreotide—thymus cancer	0.00612	0.00907	CcSEcCtD
Iloperidone—Tachycardia—Octreotide—thymus cancer	0.00609	0.00903	CcSEcCtD
Iloperidone—Musculoskeletal discomfort—Octreotide—thymus cancer	0.00568	0.00843	CcSEcCtD
Iloperidone—Paraesthesia—Octreotide—thymus cancer	0.0056	0.0083	CcSEcCtD
Iloperidone—HTR1A—hematopoietic system—thymus cancer	0.00559	0.0172	CbGeAlD
Iloperidone—Dyspnoea—Octreotide—thymus cancer	0.00556	0.00825	CcSEcCtD
Iloperidone—Somnolence—Octreotide—thymus cancer	0.00555	0.00822	CcSEcCtD
Iloperidone—Gastrointestinal disorder—Octreotide—thymus cancer	0.00539	0.00798	CcSEcCtD
Iloperidone—Fatigue—Octreotide—thymus cancer	0.00538	0.00797	CcSEcCtD
Iloperidone—HTR7—hematopoietic system—thymus cancer	0.00534	0.0164	CbGeAlD
Iloperidone—ADRA1A—hematopoietic system—thymus cancer	0.00515	0.0158	CbGeAlD
Iloperidone—Feeling abnormal—Octreotide—thymus cancer	0.00514	0.00762	CcSEcCtD
Iloperidone—Body temperature increased—Octreotide—thymus cancer	0.00493	0.00731	CcSEcCtD
Iloperidone—HTR7—epithelium—thymus cancer	0.00488	0.015	CbGeAlD
Iloperidone—SIGMAR1—cardiac atrium—thymus cancer	0.00474	0.0146	CbGeAlD
Iloperidone—ADRA1A—epithelium—thymus cancer	0.00471	0.0145	CbGeAlD
Iloperidone—SIGMAR1—pituitary gland—thymus cancer	0.00463	0.0142	CbGeAlD
Iloperidone—Asthenia—Octreotide—thymus cancer	0.00448	0.00664	CcSEcCtD
Iloperidone—HTR2A—neck—thymus cancer	0.00447	0.0137	CbGeAlD
Iloperidone—Diarrhoea—Octreotide—thymus cancer	0.00427	0.00633	CcSEcCtD
Iloperidone—CYP1A2—hematopoietic system—thymus cancer	0.00426	0.0131	CbGeAlD
Iloperidone—Dizziness—Octreotide—thymus cancer	0.00413	0.00612	CcSEcCtD
Iloperidone—CYP3A5—hematopoietic system—thymus cancer	0.00411	0.0126	CbGeAlD
Iloperidone—SIGMAR1—bone marrow—thymus cancer	0.00401	0.0123	CbGeAlD
Iloperidone—SIGMAR1—thyroid gland—thymus cancer	0.004	0.0123	CbGeAlD
Iloperidone—HRH1—hematopoietic system—thymus cancer	0.00399	0.0123	CbGeAlD
Iloperidone—Rash—Octreotide—thymus cancer	0.00393	0.00583	CcSEcCtD
Iloperidone—Dermatitis—Octreotide—thymus cancer	0.00393	0.00583	CcSEcCtD
Iloperidone—ADRA2A—hematopoietic system—thymus cancer	0.00392	0.012	CbGeAlD
Iloperidone—CYP2E1—hematopoietic system—thymus cancer	0.00383	0.0118	CbGeAlD
Iloperidone—DRD2—pituitary gland—thymus cancer	0.00374	0.0115	CbGeAlD
Iloperidone—ADRA2C—cardiac atrium—thymus cancer	0.00373	0.0115	CbGeAlD
Iloperidone—Nausea—Octreotide—thymus cancer	0.00371	0.00549	CcSEcCtD
Iloperidone—HRH1—epithelium—thymus cancer	0.00364	0.0112	CbGeAlD
Iloperidone—ADRA2C—pituitary gland—thymus cancer	0.00364	0.0112	CbGeAlD
Iloperidone—SIGMAR1—lung—thymus cancer	0.00363	0.0112	CbGeAlD
Iloperidone—ADRA1A—lymphoid tissue—thymus cancer	0.00363	0.0111	CbGeAlD
Iloperidone—HTR2A—hematopoietic system—thymus cancer	0.00333	0.0102	CbGeAlD
Iloperidone—HTR7—lung—thymus cancer	0.0031	0.00953	CbGeAlD
Iloperidone—CYP3A4—hematopoietic system—thymus cancer	0.00308	0.00947	CbGeAlD
Iloperidone—HTR2A—epithelium—thymus cancer	0.00304	0.00935	CbGeAlD
Iloperidone—CYP2D6—hematopoietic system—thymus cancer	0.00303	0.00932	CbGeAlD
Iloperidone—ADRA2A—cardiac atrium—thymus cancer	0.00297	0.00914	CbGeAlD
Iloperidone—DRD2—lung—thymus cancer	0.00293	0.00901	CbGeAlD
Iloperidone—ADRA2A—pituitary gland—thymus cancer	0.0029	0.00893	CbGeAlD
Iloperidone—ADRA2C—lung—thymus cancer	0.00285	0.00876	CbGeAlD
Iloperidone—CYP1A2—thyroid gland—thymus cancer	0.00272	0.00837	CbGeAlD
Iloperidone—CYP2E1—lymphoid tissue—thymus cancer	0.0027	0.00829	CbGeAlD
Iloperidone—ADRA2A—thyroid gland—thymus cancer	0.0025	0.00769	CbGeAlD
Iloperidone—SIGMAR1—lymph node—thymus cancer	0.00248	0.00763	CbGeAlD
Iloperidone—CYP1A2—lung—thymus cancer	0.00247	0.0076	CbGeAlD
Iloperidone—HTR2A—pituitary gland—thymus cancer	0.00247	0.00759	CbGeAlD
Iloperidone—CYP2E1—thyroid gland—thymus cancer	0.00245	0.00753	CbGeAlD
Iloperidone—CYP3A5—lung—thymus cancer	0.00239	0.00733	CbGeAlD
Iloperidone—HRH1—lung—thymus cancer	0.00232	0.00711	CbGeAlD
Iloperidone—ADRA2A—lung—thymus cancer	0.00227	0.00699	CbGeAlD
Iloperidone—CYP2E1—lung—thymus cancer	0.00222	0.00684	CbGeAlD
Iloperidone—ADRA2C—lymph node—thymus cancer	0.00195	0.00599	CbGeAlD
Iloperidone—HTR2A—lung—thymus cancer	0.00193	0.00594	CbGeAlD
Iloperidone—HRH1—lymph node—thymus cancer	0.00158	0.00487	CbGeAlD
Iloperidone—ADRA2A—lymph node—thymus cancer	0.00156	0.00478	CbGeAlD
